Khodadoust line
| Khodadoust line | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | Ophthalmology |
| Symptoms | Corneal edema, blurred vision |
| Complications | Corneal graft rejection |
| Onset | |
| Duration | |
| Types | N/A |
| Causes | Immune response to corneal transplant |
| Risks | Previous corneal transplantation |
| Diagnosis | Slit lamp examination |
| Differential diagnosis | |
| Prevention | |
| Treatment | Topical corticosteroids, immunosuppressive therapy |
| Medication | N/A |
| Prognosis | Variable, depending on response to treatment |
| Frequency | |
| Deaths | N/A |
Khodadoust Line is a clinical sign observed in corneal transplantation, named after Dr. Irvine Khodadoust, a pioneer in the field of ophthalmology. It is a line of immune cells that migrate towards the corneal graft, indicating a rejection response.
Definition[edit]
The Khodadoust Line is defined as a line of leukocytes (white blood cells) that migrate towards a corneal graft in the event of a rejection response. This line is usually visible in the corneal endothelium, the innermost layer of the cornea. The presence of the Khodadoust Line is a significant indicator of graft rejection in corneal transplantation.
History[edit]
The Khodadoust Line is named after Dr. Irvine Khodadoust, an Iranian-American ophthalmologist who first described this clinical sign in 1970. Dr. Khodadoust's extensive research in corneal transplantation and graft rejection has significantly contributed to the field of ophthalmology.
Clinical Significance[edit]
The presence of the Khodadoust Line is a clear sign of graft rejection following corneal transplantation. It is one of the earliest signs of rejection and is often accompanied by other symptoms such as decreased vision, redness, and pain. Early detection of the Khodadoust Line allows for prompt treatment, which can significantly improve the prognosis of the graft.
Treatment[edit]
The primary treatment for a rejection response indicated by the Khodadoust Line is the administration of corticosteroids, either topically or systemically. In severe cases, additional immunosuppressive therapy may be required. Early detection and treatment are crucial to prevent irreversible damage to the graft.
See Also[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
 | This ophthalmology article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
